120
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Association between single nucleotide polymorphisms of VEGF gene and pelvic lymph node metastasis in patients with early-stage cervical cancer

, , , ORCID Icon, , , & show all

References

  • Arcondéguy T, Lacazette E, Millevoi S, Prats H, Touriol C. 2013. VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level. Nucleic Acids Research 41:7997–8010.
  • Chopra V, Dinh TV, Hannigan EV. 1998. Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Investigation 16:152–159.
  • Della-Morte D, Riondino S, Ferroni P, Palmirotta R, Pastore D, Lauro D, et al. 2015. Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity. Pharmacogenomics 16:61–78.
  • Ghazizadeh H, Fazilati M, Pasdar A, Avan A, Tayefi M, Ghasemi F, et al. 2017. Association of a vascular endothelial growth factor genetic variant with serum VEGF level in subjects with metabolic syndrome. Gene 598:27–31.
  • Gien LT, Covens A. 2009. Lymph node assessment in cervical cancer: prognostic and therapeutic implications. Journal of Surgical Oncology 99:242–247.
  • Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, et al. 2003. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. International Journal of Cancer 106:468–471.
  • Pander J, Gelderblom H, Guchelaar HJ. 2007. Pharmacogenetics of EGFR and VEGF inhibition. Drug Discovery Today 12:1054–1060.
  • Saleh A, Stathopoulou MG, Dadé S, Ndiaye NC, Azimi-Nezhad M, Murray H, et al. 2015. Angiogenesis related genes NOS3, CD14, MMP3 and IL4R are associated to VEGF gene expression and circulating levels in healthy adults. BMC Medical Genetics 16:90.
  • Salimi S, Yaghmaei M, Tabatabaei E, Mokhtari M, Naghavi A. 2015. Vascular endothelial growth factor (VEGF)-634G/C polymorphism was associated with severe pre-eclampsia and lower serum VEGF level. The Journal of Obstetrics and Gynaecology Research 41:1877–1883.
  • Sawada M, Oishi T, Komatsu H, Sato S, Chikumi J, Nonaka M, et al. 2019. Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer. International Journal of Clinical Oncology 24:1612–1619.
  • Sidorkiewicz I, Zbucka-Krętowska M, Zaręba K, Lubowicka E, Zajkowska M, Szmitkowski M, et al. 2019. Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers. BMC Cancer 19:398.
  • Siregar GA, Parwati I, Achmad TH, Syukriani YF. 2018. Association between VEGF-634G > C gene polymorphism with gastric premalignant lesions and serum VEGF levels in Helicobacter pylori gastritis patients. Open Access Macedonian Journal of Medical Sciences 6:1328–1334.
  • Sun H, Tang F, Zhou S, Li X, Wang S, Huang K, et al. 2016. Association between vascular endothelial growth factor expression and lymph node metastasis in cervical cancer: a meta-analysis. Journal of Obstetrics and Gynaecology Research 42:1310–1316.
  • Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, et al. 2014. Angiogenesis and antiangiogenic agents in cervical cancer. OncoTargets and Therapy 7:2237–2248.
  • Vincenti V, Cassano C, Rocchi M, Persico G. 1996. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93:1493–1495.
  • Wang W, Jia H-L, Huang J-M, Liang Y-C, Tan H, Geng H-Z, et al. 2014. Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics. British Journal of Cancer 110:1748–1758.
  • Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, et al. 2015. Broad targeting of angiogenesis for cancer prevention and therapy. Seminars in Cancer Biology 35 Suppl.:S224–S243.
  • Wu ES, Jeronimo J, Feldman S. 2017. Barriers and challenges to treatment alternatives for early-stage cervical cancer in lower-resource settings. Journal of Global Oncology 3:572–582.
  • Yang P-W, Hsieh M-S, Huang Y-C, Hsieh C-Y, Chiang T-H, Lee J-M, et al. 2014. Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma. PLOS One 9:e100326.
  • Yin M, Liao Z, Yuan X, Guan X, O'Reilly MS, Welsh J, et al. 2012. Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy. Cancer Science 103:945–950.
  • Zhang J, Liu J, Zhu C, He J, Chen J, Liang Y, et al. 2017. Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis. Oncotarget 8:24797–24803.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.